BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15794932)

  • 1. Aromatase gene and osteoporosis: relationship of ten polymorphic loci with bone mineral density.
    Riancho JA; Zarrabeitia MT; Valero C; Sañudo C; Hernández JL; Amado JA; Zarrabeitia A; González-Macías J
    Bone; 2005 May; 36(5):917-25. PubMed ID: 15794932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in the CYP19 and AR genes--relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy: The Danish Osteoporosis Prevention Study.
    Tofteng CL; Kindmark A; Brändström H; Abrahamsen B; Petersen S; Stiger F; Stilgren LS; Jensen JE; Vestergaard P; Langdahl BL; Mosekilde L;
    Calcif Tissue Int; 2004 Jan; 74(1):25-34. PubMed ID: 14517714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of an aromatase TTTA repeat polymorphism with circulating estrogen, bone structure, and biochemistry in older women.
    Dick IM; Devine A; Prince RL
    Am J Physiol Endocrinol Metab; 2005 May; 288(5):E989-95. PubMed ID: 15613678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the 163A/G and 1181G/C osteoprotegerin polymorphism with bone mineral density.
    García-Unzueta MT; Riancho JA; Zarrabeitia MT; Sañudo C; Berja A; Valero C; Pesquera C; Paule B; González-Macías J; Amado JA
    Horm Metab Res; 2008 Mar; 40(3):219-24. PubMed ID: 18348083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A TA repeat polymorphism in the estrogen receptor gene is associated with osteoporotic fractures but polymorphisms in the first exon and intron are not.
    Langdahl BL; Løkke E; Carstens M; Stenkjaer LL; Eriksen EF
    J Bone Miner Res; 2000 Nov; 15(11):2222-30. PubMed ID: 11092403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of bone metabolism related genes polymorphisms with the effect of raloxifene hydrochloride on bone mineral density and bone turnover markers in postmenopausal women with osteoporosis.
    Zhang ZL; He JW; Qin YJ; Huang QR; Liu YJ; Hu YQ; Li M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr; 23(2):129-33. PubMed ID: 16604479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of TNFSF11 gene promoter polymorphisms with bone mineral density in postmenopausal women.
    Mencej S; Prezelj J; Kocijancic A; Ostanek B; Marc J
    Maturitas; 2006 Oct; 55(3):219-26. PubMed ID: 16730419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between polymorphisms in tumor necrosis factor (TNF) and TNF receptor genes and circulating TNF, soluble TNF receptor levels, and bone mineral density in postmenopausal Korean women.
    Kim H; Chun S; Ku SY; Suh CS; Choi YM; Kim JG
    Menopause; 2009; 16(5):1014-20. PubMed ID: 19369902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-related influence of common aromatase gene polymorphisms on bone mass of healthy men.
    Zarrabeitia A; Zarrabeitia MT; Valero C; González-Macías J; Riancho JA
    Bone; 2004 Jul; 35(1):243-8. PubMed ID: 15207764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of eNOS gene polymorphisms in relation to BMD in postmenopausal women.
    Firat SC; Cetin Z; Samanci N; Aydin F; Balci N; Gungor F; Firat MZ; Luleci G; Karauzum SB
    Maturitas; 2009 Aug; 63(4):352-6. PubMed ID: 19520527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the aromatase gene alleles with BMD: epidemiological and functional evidence.
    Riancho JA; Sañudo C; Valero C; Pipaón C; Olmos JM; Mijares V; Fernández-Luna JL; Zarrabeitia MT
    J Bone Miner Res; 2009 Oct; 24(10):1709-18. PubMed ID: 19419293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A common polymorphism in the 5'-untranslated region of the aromatase gene influences bone mass and fracture risk.
    Zarrabeitia MT; Hernández JL; Valero C; Zarrabeitia AL; García-Unzueta M; Amado JA; González-Macías J; Riancho JA
    Eur J Endocrinol; 2004 May; 150(5):699-704. PubMed ID: 15132727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of estrogen receptor beta gene polymorphisms with spinal bone mineral density in peri- and post-menopausal Greek women.
    Efstathiadou Z; Koukoulis G; Stakias N; Challa A; Zintzaras E; Tsatsoulis A
    Maturitas; 2006 Mar; 53(4):380-5. PubMed ID: 16125346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-density lipoprotein receptor-related protein 5 polymorphisms are associated with bone mineral density in Greek postmenopausal women: an interaction with calcium intake.
    Stathopoulou MG; Dedoussis GV; Trovas G; Katsalira A; Hammond N; Deloukas P; Lyritis GP
    J Am Diet Assoc; 2010 Jul; 110(7):1078-83. PubMed ID: 20630166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between the polymorphism of start codon and CDX2 site in vitamin D receptor gene and the effect of calcium supplementation on bone mineral density of postmenopausal women].
    Zhang ZL; He JW; Huang QR; Qin YJ; Hu YQ; Li M; Zhang H; Liu YJ; Hu WW
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Aug; 23(4):397-401. PubMed ID: 16883525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour necrosis factor superfamily member 11 gene promoter polymorphisms modulate promoter activity and influence bone mineral density in postmenopausal women with osteoporosis.
    Mencej S; Albagha OM; Prezelj J; Kocjan T; Marc J
    J Mol Endocrinol; 2008 Jun; 40(6):273-9. PubMed ID: 18502820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A gene-to-gene interaction between aromatase and estrogen receptors influences bone mineral density.
    Riancho JA; Zarrabeitia MT; Valero C; Sañudo C; Mijares V; González-Macías J
    Eur J Endocrinol; 2006 Jul; 155(1):53-9. PubMed ID: 16793950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between genetic polymorphisms in CYP19 and breast cancer risk in Korean women.
    Kim JY; Lee CS; Kim HO; Jo YH; Lee J; Jung MH; Baik HH; Choe W; Kang I; Yoon KS
    Oncol Rep; 2009 Sep; 22(3):487-92. PubMed ID: 19639193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women.
    Arko B; Prezelj J; Kocijancic A; Komel R; Marc J
    Maturitas; 2005 Jul; 51(3):270-9. PubMed ID: 15978970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
    Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM
    Menopause; 2007; 14(5):913-8. PubMed ID: 17667143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.